Antibiotics

Cephalosporin Antibiotic Market: Opportunities and Challenges

Sudeep Kumar Chakravarty Dec 7, 2022

Cephalosporin Antibiotic Market: Opportunities and Challenges

Cephalosporin is an antibiotic that is used to treat a variety of bacterial infections. It belongs to the class of drugs known as cephalosporins, a type of beta-lactam antibiotic that inhibits the growth of bacteria by interfering with their cell wall synthesis. Cephalosporin is effective against a wide range of bacteria, including those that cause pneumonia, bronchitis, urinary tract infections, and skin infections. It is available in various dosage forms, including oral tablets and capsules, as well as intravenous solutions for injection.

Cephalosporin Market Size and Forecast

The global cephalosporine market is nearly valued at USD 14.72 billion in 2022 and is expected to grow at a CAGR of around 2.58% and reach USD 17.15 billion by 2028. The growing prevalence of infectious diseases, increasing research and development activities, and rising demand for advanced cephalosporine antibiotics are key factors driving the market growth. In addition, the increasing government support and investments in the healthcare sector and the rising adoption of cephalosporine drugs in treating various bacterial infections are further boosting the market growth. However, the availability of alternative treatments and the stringent regulatory requirements restrain the market growth.

Reports Suggested for Cephalosporin Marketers/Manufacturers

Leading Cephalosporin Market Players

Global key market players of Cephalosporine include Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, and Hospira, etc.

China Union Chempharma (Suzhou) Co Ltd: Suzhou company specializes in cephalosporin antibiotic drugs' development, production, and sales. Product categories include oral API and sterile API. The main products are; Cefaclor, Cefdinir, Cefprozil, Cefadroxil, Cefalothin Sodium, Cefamandole Nafate, Cefmenoxime Hydrochloride, Cefpirome Sulfate, Cefoxitin Sodium, Ceftriaxone Sodium, etc.

Qilu Antibiotics Pharmaceutical Co., Ltd: The company is specialized in the production of Cephalosporin API, and the annual capacity is 1,500MT. The company has a production chain from 7-ACA to oral and injection APIs. With advanced R&D ability, several new products were first brought into industrialization in China and got awarded as a "High-New Technical Company".

Lupin Pharmaceuticals: Lupin is a global pharmaceutical company that specializes in the development, manufacture, and distribution of a wide range of drugs and healthcare products. Lupin Pharmaceuticals' cephalosporine drugs are available in various forms, including tablets, capsules, and injectable solutions. These drugs are used to treat a wide range of bacterial infections, and are known for their effectiveness and safety.

Some of the most commonly used cephalosporine drugs from Lupin Pharmaceuticals include:

Cefadroxil: This drug is used to treat numbers of bacterial infections, including skin infections, urinary tract infections, and respiratory tract infections.
Cefpodoxime: This drug is used to treat infections of the urinary tract, respiratory tract, skin, and soft tissues.
Cefixime: This drug is used to treat infections of the urinary tract, respiratory tract, and skin.
Cefotaxime: This drug treats severe bacterial infections, including pneumonia, meningitis, and septicemia.
Ceftriaxone: This drug is used to treat a wide range of bacterial infections, including pneumonia, meningitis, and septicemia.

Reports Suggested for Cephalosporine Market Investors

Cephalosporin Market Segments

First Generation cephalosporine: The first-generation cephalosporines include cefazolin, cephalexin, and cefadroxil. These antibiotics are effective against a wide range of bacteria, including Gram-positive and Gram-negative bacteria.
Second Generationcephalosporine: Second-generation cephalosporine antibiotics are derived from the first generation cephalosporins and have a broader spectrum of activity against gram-negative bacteria. Some examples of second-generation cephalosporines include cefuroxime, cefoxitin, and cefaclor.
Third Generationcephalosporine: Third-generation cephalosporins encompassed among the beta-lactam class of drugs. The third-generation class of cephalosporins is the most commonly prescribed group. These cephalosporins are semisynthetic analogs with different chemical substitutions on the C7 acylamido chain. Some examples of third-generation cephalosporins include ceftriaxone, cefotaxime, and ceftazidime.
Fourth Generationcephalosporine: Examples of fourth-generation cephalosporines include cefepime, cefpirome, and cefozopran. These antibiotics are typically reserved for severe or complicated infections and may be used in combination with other antibiotics to improve their effectiveness.

7-Aminocephalosporanic acid (7-ACA) is a molecule that is used as a starting material in the synthesis of cephalosporin antibiotics. These antibiotics are used to treat a wide range of bacterial infections, including pneumonia, bronchitis, and urinary tract infections. 7-ACA is also used in producing semi-synthetic cephalosporins, which are more effective and have a longer shelf life than naturally-occurring cephalosporins.

Reports Suggested for Cephalosporin Chemical/Salt/API Manufacturers

Disclaimer: The products mentioned here are not intended to diagnose, treat, cure, or prevent any disease. The information provided on this blog is marketing material for the informational purposes of pharma manufacturers, investors, and chemical manufacturers and should not be considered medical advice. Always consult with a qualified healthcare professional before taking any medication or supplement.